Acinetobacter calcoaceticus: Detection and Clinical Overview

Acinetobacter calcoaceticus belongs to the genus Acinetobacter within the family Moraxellaceae and class Gammaproteobacteria. It is one of the clinically relevant members of the Acinetobacter calcoaceticus–baumannii complex, which also includes A. baumannii and related species.

This bacterium is Gram-negative, pleomorphic, and typically appears as short rods or coccobacilli. It is non-motile, non-spore-forming, and some strains may possess a capsule. Under microscopy, cells often appear in pairs or short chains and may resemble diplococci, leading to potential misidentification during initial examination.

Biochemically, it is oxidase negative and catalase positive. It does not ferment glucose but can efficiently utilize acetate as a sole carbon source, a defining metabolic feature reflected in its species name.

Acinetobacter calcoaceticus demonstrates strong environmental resilience and is widely distributed in soil, water, air particulates, and on various surfaces. It can survive for extended periods under dry conditions, contributing to its persistence and transmission across different environments.

In healthcare settings, it commonly colonizes medical devices such as ventilator circuits, central venous catheters, and urinary catheters, as well as high-contact surfaces including bed rails, bedside tables, and healthcare workers’ hands.

Transmission primarily occurs via contact, particularly through contaminated hands or medical equipment. It poses a significant risk to immunocompromised individuals, including ICU patients, cancer patients undergoing chemotherapy, and organ transplant recipients.

Acinetobacter calcoaceticus is associated with a range of opportunistic infections, particularly in hospitalized patients. Common clinical presentations include ventilator-associated pneumonia, urinary tract infections, bloodstream infections, and wound infections.

In severe cases, infection can lead to systemic complications, especially in critically ill or immunocompromised individuals. Its role within the Acinetobacter complex makes it clinically significant, although differentiation from closely related species is often required for accurate diagnosis and epidemiological tracking.

Conventional laboratory identification relies on culture and biochemical testing. Acinetobacter calcoaceticus grows well on common media such as blood agar and MacConkey agar under aerobic conditions at 35–37°C. Colonies typically appear after 18–24 hours as smooth, moist, grayish-white, semi-translucent, and non-hemolytic.

However, due to phenotypic similarity with other members of the Acinetobacter calcoaceticus–baumannii complex, conventional methods often fail to distinguish species accurately. Advanced identification techniques such as MALDI-TOF MS and 16S rRNA gene sequencing are commonly used for precise classification.

PCR and real-time qPCR assays provide rapid, sensitive, and specific detection of Acinetobacter calcoaceticus, making them valuable tools for clinical diagnostics, environmental monitoring, and infection control surveillance.

Management of Acinetobacter calcoaceticus infections depends on antimicrobial susceptibility profiles, which may vary among strains. As part of the Acinetobacter complex, resistance to multiple antibiotics can occur, necessitating careful selection of therapeutic agents based on susceptibility testing.

In healthcare environments, prevention is critical. Key infection control strategies include strict hand hygiene, proper sterilization and disinfection of medical devices, and routine monitoring of high-risk patients. Early detection and isolation of colonized or infected individuals are essential to limit nosocomial spread.

Environmental decontamination and adherence to infection prevention protocols play a central role in controlling outbreaks associated with this organism.